Starbucks is responding to the rising health trend of protein consumption by testing a new protein-infused cold foam for its coffee drinks.
This move aligns with growing consumer interest in protein for general wellness, muscle maintenance, and weight management, especially among people using appetite-suppressing medications like Ozempic and Wegovy.
The protein cold foam adds about 15 grams of protein to beverages and can be mixed with any cold foam flavor, offering a convenient way for customers to boost their protein intake without extra effort.
CEO Brian Niccol observed customers adding their own protein powders or drinks to espresso, inspiring Starbucks to create a better, integrated option. This protein innovation is part of Starbucks’ “Back to Starbucks” plan to revive sales and foot traffic by focusing on core consumer needs and trends.
The test is currently underway in five U.S. locations, targeting a broad demographic including young adults, older adults, and those on GLP-1 drugs.
Starbucks previously offered protein smoothies but discontinued them in 2018; the new protein cold foam represents a fresh approach to meet today’s health-conscious consumers.
The trend toward protein is no longer limited to athletes but has become mainstream, appealing to a wide range of consumers seeking convenient, tasty, and healthful options.
Protein’s role in supporting muscle health and satiety makes it especially relevant as millions of Americans adopt GLP-1 medications for weight management. Starbucks’ protein coffee innovation taps into this shift, potentially setting a new standard in the coffee and wellness market.
Read more:
- Is “High Protein” Just a Marketing Gimmick? What Science Really Says
- Protein Markers May Help Detect Middle-Age Dementia Early
- Collagen Protein Bars May Help People Lose Weight Safely, Study Finds
